facebook-page-view
Advertisement

Symbiotec Pharmalab Pvt Ltd

Premium
Bottomline: InvAscent-backed Symbiotec has struggled to break out; will FY25 be different?

Healthcare

19 January, 2024

Bottomline: InvAscent-backed Symbiotec has struggled to break out; will FY25 be different?

Homegrown corticosteroid and hormones API-maker Symbiotec Lifesciences Pvt. Ltd’s revenue and profitability took a hit in FY23, even as the ......

Premium
Why Indian bulk-drug makers are attracting greater investor interest

Healthcare

06 November, 2019

Why Indian bulk-drug makers are attracting greater investor interest

Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry executives ......

Motilal Oswal PE-InvAscent consortium buys out Actis from Symbiotec

Healthcare

18 December, 2018

Motilal Oswal PE-InvAscent consortium buys out Actis from Symbiotec

A consortium of mid-market private equity firms InvAscent and Motilal Oswal PE has bought British PE firm Actis' entire stake ......

Premium
Mid-market PE consortium in talks to buy Actis' stake in Symbiotec

Healthcare

20 September, 2018

Mid-market PE consortium in talks to buy Actis' stake in Symbiotec

Actis Advisers Pvt. Ltd is in the final stages of negotiations with a consortium of fellow private equity firms to ......

Premium
Symbiotec Pharmalab gets interest from new set of PE firms

Healthcare

12 June, 2017

Symbiotec Pharmalab gets interest from new set of PE firms

Symbiotec Pharmalab Pvt. Ltd has attracted interest from a new set of global private equity investors, as majority owner Actis ......

Premium
Actis in talks with marquee PE firms, pharma co to sell Symbiotec stake

Healthcare

13 April, 2017

Actis in talks with marquee PE firms, pharma co to sell Symbiotec stake

Private equity (PE) firm Actis Advisers Pvt. Ltd. has engaged an investment bank for the sale of its majority stake ......